Skip to content

The case-control study on micronutrient levels in children with attention deficit hyperactivity disorder in the real world

The case-control study on micronutrient levels in children with attention deficit hyperactivity disorder in the real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107486
Enrollment
Unknown
Registered
2025-08-12
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attention deficit hyperactivity disorder

Interventions

Sponsors

Shenzhen Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. ADHD children:Age between 6 and 12 years (inclusive), regardless of gender. Diagnosed with ADHD in the hospital information system between January 1, 2015, and December 31, 2024. The serum micronutrient test was completed within three months before and after the first diagnosis of ADHD; 2. Normal Children:Aged 6–12 years (inclusive), regardless of gender. Diagnosed with "health check-up" in the hospital information system between January 1, 2015, and December 31, 2024. Completed serum micronutrient testing.

Exclusion criteria

Exclusion criteria: 1. ADHD children: Co-diagnosed with: Growth disorders (e.g., short stature) Metabolic diseases (e.g., diabetes) Liver diseases (e.g., hepatitis, fatty liver, cholestatic liver disease) Kidney diseases (e.g., nephrotic syndrome, chronic kidney disease) Presence of other severe neurological disorders (e.g., epilepsy, cerebral palsy) or inherited metabolic diseases. Incomplete data or missing serum micronutrient test results. 2. Normal children:Diagnosed with any of the following conditions: ADHD,Growth disorders (e.g., short stature) Metabolic diseases (e.g., diabetes) Liver diseases (e.g., hepatitis, fatty liver, cholestatic liver disease) Kidney diseases (e.g., nephrotic syndrome, chronic kidney disease) Presence of other severe neurological disorders or inherited metabolic diseases Incomplete clinical data or unavailable serum micronutrient test results;

Design outcomes

Primary

MeasureTime frame
serum micronutrients;

Secondary

MeasureTime frame
Diagnosis of the disease and medication use in children with ADHD;Visiting time, date of birth, age, gender;

Countries

China

Contacts

Public ContactCao Xiaolan

Shenzhen Children’s Hospital

amao831@163.com+86 18924657278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026